14B · Registry Watch

Registry Watch

Erasca says 44% of 25 responded; it’s Phase 1 · No. 052 · · About 4 min read

Bookmarks need a Mind Club sign-in. How sign-in works

All 70 watchlist trials were pulled today, and none changed since 11.19 in status, enrollment, primary outcome or dates. Three have posted results. The full list, by primary completion date, runs on Fridays.

TrialPhaseStatusNPrimary completion
ANTHEM-UC (icotrokinra UC) Ph2b · NCT06049017 (opens another website in a new tab)Phase 2Completed25209.26.2024
Explore-CKD · NCT06150924 (opens another website in a new tab)Phase 2Completed6002.27.2025
TransportNPC · NCT04860960 (opens another website in a new tab)Phase 3Unknown9406.2025
SatraGO-1 (satralizumab TED) · NCT05987423 (opens another website in a new tab)Phase 3Completed13107.08.2025
SatraGO-2 (satralizumab TED) · NCT06106828 (opens another website in a new tab)Phase 3Completed12707.24.2025
ZUPREME-1 · NCT06662539 (opens another website in a new tab)Phase 2Completed49309.30.2025
B-Well 2 · NCT05630820 (opens another website in a new tab)Phase 3Completed85711.03.2025
B-Well 1 · NCT05630807 (opens another website in a new tab)Phase 3Completed98111.11.2025
RINGSIDE · NCT04871282 (opens another website in a new tab)Phase 2/3Active, not recruiting19812.03.2025
SYNCHRONIZE-2 · NCT06066528 (opens another website in a new tab)Phase 3Completed75512.12.2025
Olatorepatide (HS-20094) LIGHTEN Ph3 · NCT06839664 (opens another website in a new tab)Phase 3Completed60401.04.2026
TALAPRO-3 · NCT04821622 (opens another website in a new tab)Phase 3Active, not recruiting59902.18.2026
ACHIEVE-4 · NCT05803421 (opens another website in a new tab)Phase 3Completed2,74903.16.2026
Tulisokibart HS Ph2b · NCT06956235 (opens another website in a new tab)Phase 2Active, not recruiting14904.02.2026
OVX836 Ph2b (Osivax) · NCT05569239 (opens another website in a new tab)Phase 2Completed2,89105.18.2026
Krascendo 1 (divarasib NSCLC) Ph3 · NCT06497556 (opens another website in a new tab)Phase 3Active, not recruiting33805.19.2026
CLARITY-Gastric01 Ph3 · NCT06346392 (opens another website in a new tab)Phase 3Active, not recruiting59405.31.2026
Afimetoran SLE Ph2 · NCT04895696 (opens another website in a new tab)Phase 2Active, not recruiting24806.12.2026
TRIUMPH-2 · NCT05929079 (opens another website in a new tab)Phase 3Completed1,15206.16.2026
COURAGE (trevogrumab) Ph2 · NCT06299098 (opens another website in a new tab)Phase 2Completed1,00506.16.2026
ARTEMIS-011 · NCT06935409 (opens another website in a new tab)Phase 3Completed12206.17.2026
MRT-8102 Ph1 · NCT07119125 (opens another website in a new tab)Phase 1Active, not recruiting10007.2026
EloraTZP Ph2 · NCT06603571 (opens another website in a new tab)Phase 2Completed36707.01.2026
SAFFRON (savolitinib) Ph3 · NCT05261399 (opens another website in a new tab)Phase 3Active, not recruiting34107.06.2026
CROSSING (tezepelumab, EoE) Ph3 · NCT05583227 (opens another website in a new tab)Phase 3Active, not recruiting36807.14.2026
Seabreeze STAT · NCT06940154 (opens another website in a new tab)Phase 2Completed15907.30.2026
ARISE (solengepras, Parkinson’s) Ph3 · NCT06553027 (opens another website in a new tab)Phase 3Active, not recruiting33008.2026
ZP9830 Phase 1 · NCT06682975 (opens another website in a new tab)Phase 1Recruiting12408.2026
Tulisokibart UC Ph3 · NCT06052059 (opens another website in a new tab)Phase 3Active, not recruiting1,10908.12.2026
BMF-650 Ph1 · NCT07223216 (opens another website in a new tab)Phase 1Completed9008.12.2026
DYNASTY-Breast02 Ph3 · NCT06018337 (opens another website in a new tab)Phase 3Active, not recruiting54108.12.2026
WHISTLE-PF (taladegib IPF) · NCT06422884 (opens another website in a new tab)Phase 2Completed21308.21.2026
MAXPIRe (axatilimab IPF) Ph2 · NCT06132256 (opens another website in a new tab)Phase 2Completed14508.27.2026
TRANSCEND-T2D-2 · NCT06260722 (opens another website in a new tab)Phase 3Active, not recruiting1,25008.27.2026
HERMES (ziltivekimab HFpEF) Ph3 · NCT05636176 (opens another website in a new tab)Phase 3Terminated4,87409.03.2026
APOLLO, bitopertin EPP · NCT06910358 (opens another website in a new tab)Phase 3Completed18309.08.2026
CLARITY (brepocitinib, uveitis) Ph3 · NCT06431373 (opens another website in a new tab)Phase 3Active, not recruiting37109.11.2026
OPUS-1 (VAX-31 adults) · NCT07284654 (opens another website in a new tab)Phase 3Completed4,04909.17.2026
HARMONi-GI1 Ph3 · NCT06591520 (opens another website in a new tab)Phase 3Active, not recruiting68210.2026
FURVENT (firmonertinib 1L EGFR ex20 NSCLC) · NCT05607550 (opens another website in a new tab)Phase 3Active, not recruiting39810.06.2026
ALOFT-IPF (admilparant) · NCT06003426 (opens another website in a new tab)Phase 3Active, not recruiting1,25510.06.2026
LIBREXIA-STROKE (milvexian) Ph3 · NCT05702034 (opens another website in a new tab)Phase 3Active, not recruiting12,52310.15.2026
EVERLAST-B · NCT07290569 (opens another website in a new tab)Phase 2Active, not recruiting16010.21.2026
ALTITUDE-AD (Acumen sabirnetug) · NCT06335173 (opens another website in a new tab)Phase 2Active, not recruiting54210.29.2026
APEX (APG777) Ph2 · NCT06395948 (opens another website in a new tab)Phase 2Active, not recruiting47011.2026
Tilrekimig AD Ph2 · NCT05995964 (opens another website in a new tab)Phase 2Active, not recruiting50711.12.2026
ACTION-1 (RYZ101) · NCT05477576 (opens another website in a new tab)Phase 3Active, not recruiting34312.2026
VQW-765 Study 3201 Ph3 · NCT07221578 (opens another website in a new tab)Phase 3Active, not recruiting50012.2026
FB102-301 (celiac) Ph2 · NCT06982963 (opens another website in a new tab)Phase 2Recruiting10002.28.2027
Ubamatamab Ph1/2 · NCT03564340 (opens another website in a new tab)Phase 1/2Recruiting89005.10.2027
KEYNOTE-C93 · NCT05173987 (opens another website in a new tab)Phase 3Active, not recruiting28005.27.2027
EPCORE DLBCL-2 (epcoritamab + R-CHOP) · NCT05578976 (opens another website in a new tab)Phase 3Active, not recruiting90006.2027
ARO-MAPT Ph1/2a · NCT07221344 (opens another website in a new tab)Phase 1/2Recruiting16006.2027
TUPELO (REC-4881, FAP) · NCT05552755 (opens another website in a new tab)Phase 1/2Recruiting6706.2027
UNITY (efgartigimod SC, Sjogren’s) Ph3 · NCT06684847 (opens another website in a new tab)Phase 3Active, not recruiting63107.2027
FORTIFY (BBP-418) · NCT05775848 (opens another website in a new tab)Phase 3Active, not recruiting11209.2027
Combi-TED, Tedopi · NCT04884282 (opens another website in a new tab)Phase 2Active, not recruiting10509.30.2027
EXCALIBER-RRMM (iberdomide) · NCT04975997 (opens another website in a new tab)Phase 3Active, not recruiting93911.16.2027
C-POST Ph3 · NCT03969004 (opens another website in a new tab)Phase 3Active, not recruiting41501.07.2028
TroFuse-005 · NCT06132958 (opens another website in a new tab)Phase 3Active, not recruiting71001.10.2028
IMAgINATION (sefaxersen IgAN) Ph3 · NCT05797610 (opens another website in a new tab)Phase 3Active, not recruiting45905.25.2028
SANOVO Ph3 · NCT05009836 (opens another website in a new tab)Phase 3Active, not recruiting41205.30.2028
Duvakitug HS Ph2b · NCT07812116 (opens another website in a new tab)Phase 2Recruiting15606.16.2028
Vortosiran AF Ph2b (Ribocure) · NCT07870889 (opens another website in a new tab)Phase 2Not yet recruiting15007.31.2028
VS-7375 TARGET-D 101 · NCT07020221 (opens another website in a new tab)Phase 1/2Recruiting61612.2028
AHEAD-MERIT (BNT113) · NCT04534205 (opens another website in a new tab)Phase 2/3Active, not recruiting35804.2029
MOIO · NCT05078047 (opens another website in a new tab)Phase 3Active, not recruiting64605.07.2029
AMT-130 Ph1/2 · NCT04120493 (opens another website in a new tab)Phase 1/2Active, not recruiting4306.2029
TARGET-CD, ABBV-466 · NCT06548542 (opens another website in a new tab)Phase 2Recruiting59001.2030
DeLLphi-305 (tarlatamab + durvalumab ES-SCLC) Ph3 · NCT06211036 (opens another website in a new tab)Phase 3Active, not recruiting56304.02.2030

ClinicalTrials.gov watchlist, pulled 11.20.2026 through the registry’s API Reg. N is actual or planned enrollment as registered. A listed completion date is the sponsor’s estimate and can move.